US2017360982A1PendingUtilityA1
Wound Healing Composition Involving Mineral Ions and Methylglyoxal, and Methods of Use
Est. expiryJan 29, 2035(~8.5 yrs left)· nominal 20-yr term from priority
A61P 31/00A61P 29/00A61P 17/02A61L 15/46A61L 2300/102A61K 31/121A61L 2300/216A61L 26/0066A61L 15/20A61L 15/40A61L 26/0057A61K 31/11A61K 33/04A61L 2300/30A61K 35/644A61K 33/00A61L 2300/404A61K 33/06A61K 9/0014A61K 33/30A61K 47/10
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides compositions based on an effective amount of an active anti-inflammatory ingredient of mineral solids fortified with methylglyoxal antibacterial activity for the treatment of wounds; and methods of treating a wound, comprising contacting a wound with the above compositions or a wound dressing containing the above compositions.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1 . A wound healing composition, comprising:
a pharmaceutically acceptable carrier; an effective amount of an active ingredient of mineral solids, said mineral solids including at least one of a magnesium salt, a potassium salt, a calcium salt, a zinc salt, a rubidium salt, a bromide salt, and a sulfate salt; and a concentration of methylglyoxal effective to reduce a number of microorganisms at a wound site being added to said active ingredient.
2 . The wound healing composition of claim 1 , wherein each of the salts includes a pharmaceutically-acceptable counterion.
3 . The wound healing composition of claim 1 , wherein the active ingredient of mineral solids includes 1.5-75 parts of magnesium ions, 0.5-75 parts of potassium ions, 0.001-10 parts of calcium ions, 0.0001-10 parts of zinc ions, up to 5 parts of rubidium ions, 0.001-20 parts of bromide ions, and up to 20 parts of sulfate ions, said parts expressing a mass of a respective ions divided by a total mass of the mineral solids.
4 . The wound healing composition of claim 1 , wherein said methylglyoxal added to said active ingredient ranges from 500 to 2000 mg per kg of the composition.
5 . The wound healing composition of claim 1 , wherein the pharmaceutically-acceptable carrier includes at least one of water, polyethylene glycol, an ointment, and a cream base.
6 . The wound healing composition of claim 1 , wherein a pH of the composition is between 3.0-7.0.
7 . The wound healing composition of claim 1 , wherein the wound healing composition is replaced on a wound at least once.
8 . A wound healing dressing, comprising:
the wound healing composition according to claim 1 ; and a support.
9 . The wound healing dressing of claim 8 , wherein the support includes at least one of a fibrous gauze material, a hydrogel, a foam, a film, a hydrocolloid, a collagen, and an alginate.Join the waitlist — get patent alerts
Track US2017360982A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.